Format

Send to

Choose Destination
See comment in PubMed Commons below
Med Clin (Barc). 2012 Sep 22;139(7):295-9. doi: 10.1016/j.medcli.2012.01.027. Epub 2012 Mar 28.

[Colchicine: what's up, doc?].

[Article in Spanish]

Author information

1
Servicio de Farmacia, Hospital Universitario La Paz, Madrid, España. evillabueno@telefonica.net

Abstract

Over de past years use off-label of colchicine has notably increased, mainly as a result of the latest studies published about its efficacy in the prevention of recurrence after acute or recurrent pericarditis and pericarditis after cardiac surgery. Nevertheless, colchicine use has been associated with serious drug interactions and toxicity with high morbimortality. Taking into account the recent results about the efficacy of colchicine in pericarditis management, we envisage an increase in the use of this drug by clinicians. In this review we analyse the risks and current recommendations for a safety use of this ancient drug.

PMID:
22459571
DOI:
10.1016/j.medcli.2012.01.027
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center